Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4300 Bartlett St
Homer, AK 99603Phone+1 907-235-8101Fax+1 907-235-0877
Education & Training
University of Utah HealthResidency, Family Medicine, 1979 - 1982- University of Utah HealthInternship, Transitional Year, 1978 - 1979
Indiana University School of MedicineClass of 1978
Certifications & Licensure
AK State Medical License 1983 - 2024
UT State Medical License 1979 - 2024
WA State Medical License 1989 - 2019
HI State Medical License 1988 - 2018
Awards, Honors, & Recognition
- Fellow (FACEP) American College of Emergency Physicians
Publications & Presentations
PubMed
- Corrigendum to "Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase" [Antivir. Res. 218 (2023) 105716-105728, doi: 10.1016/j.antivi...Ryan P Bennett, Yasemin Yoluç, Jason D Salter, Alexander Ripp, Henning J Jessen
Antiviral Research. 2023-11-01 - 1 citationsSangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase.Ryan P Bennett, Yasemin Yoluç, Jason D Salter, Alexander Ripp, Henning J Jessen
Antiviral Research. 2023-10-01 - 6 citationsRegulation of Antiviral Innate Immunity Through APOBEC Ribonucleoprotein Complexes.Jason D. Salter, Bogdan Polevoda, Ryan P. Bennett, Harold C. Smith
Sub-Cellular Biochemistry. 2019-01-01
Press Mentions
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory BoardJune 2nd, 2021
Grant Support
- Development Of A Novel HIV/AIDS Therapeutic Activating The APOBEC3G Host DefenseNational Institute Of Allergy And Infectious Diseases2011
- Development Of A High Throughput Screen For Antagonists Of Vif DimerizationNational Institute Of Neurological Disorders And Stroke2009–2011
- Based Deamination By CEM15 Suppresses HIV-1 InfectivityNational Institute Of Allergy And Infectious Diseases2004–2005
- The Role Of MRNA Editing In B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2004
- Role Of MRNA Editing In B Cell DevelopmentNational Institute Of Allergy And Infectious Diseases2003
- Metabolic Regulation Of Apolipoprotein B MRNA EditingNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2003
- Metabolic Regulation Of APO B MRNA EditingNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
